GlassScriptPhysician profile
Apryl Cronley
NPI 1679149157
$2,723.34
in general payments reported to CMS, 2019-2025
22 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.23 · 2024: $821 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,565 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,565.11 |
| Education | $145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $539.51 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $380.04 | 2024-2025 | Assure Wcd |
| Novo Nordisk INC | $345.85 | 2024-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $328.74 | 2025 | Ensite, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Abiomed | $195.46 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $172.08 | 2024-2025 | Farxiga |
| Pfizer INC. | $119.52 | 2024-2025 | |
| Medtronic, INC. | $109.98 | 2024-2025 | Micra, Azure Xt Dr Mri Surescan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.92 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $81.62 | 2024-2025 | General - Brady, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $71.58 | 2024-2025 | Camzyos |
| Cvrx, INC. | $54.39 | 2025 | Barostim Neo System |
| Scpharmaceuticals INC. | $34.51 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $34.44 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $29.94 | 2024 | Xarelto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $24.48 | 2025 | Flowtriever |
| Inari Medical, INC. | $23.93 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $23.22 | 2025 | |
| Amgen INC. | $20.59 | 2024 | Repatha |
| Merck Sharp & Dohme LLC | $19.14 | 2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $16.17 | 2025 | |
| Abbvie INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apryl Cronley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.